Migrate From Beluga Health to TEHR: An Operator’s Guide

Why does Beluga’s integration model shape the project?

As of October 22, 2026, Beluga describes direct integration, hosted intake and platform-partner paths. Its pharmacy and labs page also describes flexible pharmacy arrangements. A business may therefore have important commerce, portal or partner components outside the clinical backend.

List the components your brand uses and identify which are owned, licensed or operated by another party. Decide whether the TEHR project will replace the whole stack or only selected workflows. Retaining a useful front end can be reasonable, but it creates interfaces that need clear responsibility.

Review TEHR versus Beluga Health and Beluga alternatives before setting the migration scope. The decision should reflect your preferred operating model. It should not rest on an unsupported assertion that Beluga requires pharmacy lock-in, takes a revenue share or lacks switching support.

Which system is the source of truth for each record?

In a connected stack, different systems may own different facts. The commerce system may know the customer’s purchase and renewal date, while the clinical system holds the encounter and medical record. The pharmacy may maintain the definitive fulfillment state. Start by identifying those sources rather than assuming one export contains everything.

Write a data ownership and synchronization map. For each important field, record where it originates, which systems copy it and which system should control it after the transition. Pay particular attention to statuses with similar names but different meanings, such as an active account, an active subscription and an active treatment episode.

Use the migration checklist to build a baseline inventory. Then ask the destination team to demonstrate how these facts will remain connected in TEHR. The goal is to preserve a usable operating picture, not merely relocate files into a new database.

How should identifiers and interfaces be mapped?

Create stable links between patient, encounter, order, subscription and partner identifiers where available. Keep the original identifiers in the mapping record so that historical issues can be traced back to the source. Do not silently replace missing identifiers with guesses.

For any retained system, document the new interface and its failure behavior. A connection that works once during a demonstration still needs a plan for delayed events, retries and conflicting updates during normal operations.

What should happen to the existing commerce and payment stack?

Decide whether to retain or replace the current storefront, account system and merchant arrangement. Make that decision deliberately: moving clinical infrastructure does not necessarily require replacing every commercial component, and keeping everything does not automatically produce the simplest operating model.

Build a subscription ledger with price, interval, next charge date, status and relevant customer terms. Identify existing pauses, cancellations and refund obligations. Verify payment-token handling with the actual payment provider; do not assume that a clinical data transfer also moves saved billing credentials.

Beluga’s pricing page states that it takes no cut of customer revenue. TEHR also uses 0% revenue share, with a flat platform subscription and flat transaction fee. Compare current written quotes and scope rather than treating no revenue share as a unique reason to switch. Use TEHR pricing and the cost guide for that analysis.

How should clinical and pharmacy continuity be planned?

Ask the receiving clinical organization to define what it needs for ongoing patients. Historical records can support evaluation, but they do not dictate a new provider’s decisions. Identify patients awaiting information, laboratory results, follow-up or an appropriate prescribing decision before moving their active workflow.

If the business intends to retain a pharmacy relationship, confirm the actual routing and contracting arrangements for the destination. If it changes pharmacies, map open prescriptions and orders separately from future activity. A data field identifying the prior pharmacy is not itself an instruction or authorization for a new fulfillment process.

Give each unresolved item an owner during overlap. The TEHR demonstration should show how staff can see whether an issue belongs to the former or new workflow. That clarity is particularly important when a patient contacts ordinary support about a clinical concern or an order that began before the transition.

What authority and privacy checks come before transfer?

Determine the permitted purpose and recipient for each dataset, including whether it contains clinical records, marketing information or commercial history. HHS treatment, payment and operations guidance describes permissions with limits; it does not mean every cross-company transfer is automatically authorized.

Review agreements and access controls with the responsible parties. Preserve applicable consent information and restrictions, including any specially protected records. An existing integration agreement should not be assumed to cover a different destination or a new use of the data.

Plan how patients will obtain older records after the transition. The source archive, destination record and patient portal may serve different purposes. Use a secure, documented transfer process and reconcile the received files against the agreed manifest. A clear audit trail helps resolve omissions or disputed mappings without repeatedly circulating sensitive information between teams.

How should event-driven workflows be tested?

Test the actual sequence of customer and service events, including failures. A payment may succeed before an intake is complete; an intake may be submitted twice; an outcome event may arrive later than expected. The destination and retained systems need to handle these conditions without creating duplicate orders or misleading messages.

Define how retries are recognized and how conflicting events are resolved. Confirm that a cancellation in one system reaches the system responsible for the next charge. Check that a clinical outcome is not overwritten by a generic commerce status. These are implementation acceptance criteria, not claims about a defect in the current vendor.

Run the pilot with representative records and controlled test scenarios. Track both counts and relationships, then reconcile exceptions before increasing volume. The TEHR migration process should produce a written test plan for your architecture. If you keep a custom front end, include the team that maintains it in the release decision.

How should patients and staff be prepared?

Explain the change in terms a patient can use: where to sign in, how to reach support, whether any action is required and how current care questions will be handled. Avoid describing a technical backend change as a guarantee that all treatment continues without review.

Prepare staff for the temporary coexistence of systems. They should know how to locate the appropriate record, identify the workflow responsible for an open issue and avoid changing the same item in two places. Give them a simple escalation map with named operational and clinical contacts.

Coordinate messages with account readiness and billing dates. A well-written announcement can still create problems if the new portal is not usable or if support has not received the instructions. The launch planning framework offers useful readiness gates, but an existing patient population adds continuity work that must be scheduled explicitly.

What determines a realistic Beluga-to-TEHR timeline?

Beluga publishes an inbound switching process. That is evidence of its approach to moving customers into Beluga, not a promise about the exports or timing for leaving your particular arrangement. Request your actual outbound terms and available data before setting the destination schedule.

Build the TEHR timeline around discovery, data mapping, retained-system integration, clinical continuity, pilot validation and staged cutover. Identify the longest external dependency early, such as a payment-provider process or source export. A good schedule makes those constraints visible instead of compressing them into an unsupported headline.

TEHR’s operators migrated thousands of their own patients and use that experience in scoped transition planning. Contact TEHR for a specific plan and quote. Review white-label platform options if you are still choosing a destination. The final decision should produce a simpler, accountable operation for your business, with no assumptions hidden in the handoff.

What else should you know?